Today: 7 February 2026
Subscribe
Browse Category

Nasdaq Updates News 22 December 2025 - 3 February 2026

Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares

Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares

Liminatus Pharma shares jumped 29.4% to $0.74 in premarket trading Tuesday after surging 64.6% to $0.94 in Monday’s after-hours session. The stock remains below the $1 minimum required for Nasdaq listing, with the company facing a July 14, 2026 deadline to regain compliance. Liminatus disclosed it received a Nasdaq deficiency notice in January. Market cap stood near $15.5 million.
3 February 2026
····
Walmart stock pops after hours as Nasdaq-100 add looms and Google Gemini deal keeps traders watching

Walmart stock pops after hours as Nasdaq-100 add looms and Google Gemini deal keeps traders watching

New York, January 13, 2026, 6:07 PM (EST) — After-hours Walmart’s stock climbed roughly 2% in after-hours on Tuesday, settling near $120.36. This shift is significant since Walmart is set to join the Nasdaq-100 on Jan. 20, landing it in a popular benchmark tracked by numerous index funds and ETFs. When a stock is added, these passive funds usually need to buy shares to keep up with the index, regardless of any changes in the company’s fundamentals. (Investopedia) Walmart climbed roughly 3% on Monday, with investors gearing up for the upcoming reshuffle. Reuters noted the move might trigger billions in
14 January 2026
·····
Regencell Bioscience (RGC) stock drops 20% in Nasdaq trade as volatility flares again

Regencell Bioscience (RGC) stock drops 20% in Nasdaq trade as volatility flares again

New York, Jan 13, 2026, 14:12 EST — Regular session Shares of Regencell Bioscience Holdings Limited dropped over 20% on Tuesday, continuing a volatile streak that has kept the Nasdaq-listed microcap in the spotlight on momentum trackers. The decline is significant because the stock has proven it can swing sharply with little notice, a pattern that can catch late buyers off guard and trigger rapid sell-offs when liquidity dries up. The spotlight returns to what usually moves this stock daily: price action and positioning, rather than a steady stream of news. Investors are asking less “what changed” and more “how
13 January 2026
····
PENN Entertainment Stock (NASDAQ: PENN) Update: Friday’s Rebound, Fresh Analyst Commentary, and What to Watch Before Monday’s Open

PENN Entertainment Stock (NASDAQ: PENN) Update: Friday’s Rebound, Fresh Analyst Commentary, and What to Watch Before Monday’s Open

NEW YORK, Dec. 28, 2025, 3:14 a.m. ET — Market closed PENN Entertainment, Inc. (NASDAQ: PENN) heads into the final week of 2025 with its stock trying to stabilize after a choppy stretch—and with Wall Street still debating the company’s post-ESPN digital playbook. Because U.S. stock markets are closed for the weekend, investors are looking at Friday’s close as the most recent real-time scorecard. PENN finished Friday’s session at $15.10, up 3.14%, outperforming several gaming peers on a day when major indexes were slightly lower. MarketWatch Where PENN stock left off before the weekend Friday’s move mattered less for the
28 December 2025
·····
BillionToOne Stock (NASDAQ: BLLN) News: Weekend Market Wrap, Analyst Targets, and What to Watch Before Monday’s Open

BillionToOne Stock (NASDAQ: BLLN) News: Weekend Market Wrap, Analyst Targets, and What to Watch Before Monday’s Open

NEW YORK, Dec. 27, 2025, 7:14 p.m. ET — Market closed BillionToOne, Inc. (NASDAQ: BLLN) heads into the weekend with investors digesting a sharp late-December selloff-and-bounce sequence that has become characteristic of newly public, high-growth healthcare names. Shares finished the last regular session (Friday, Dec. 26) at $89.30, up 3.43% on the day after trading between $85.62 and $89.99. Investing.com Because U.S. stock exchanges are closed on weekends, BLLN will not print new on-exchange prices again until the next regular session. The market backdrop is also a key part of the story: major U.S. indexes ended a quiet, holiday-shortened week
28 December 2025
·····
Firefly Aerospace Stock (NASDAQ: FLY): Latest News, Analyst Targets, and What to Watch Before Monday’s Market Open

Firefly Aerospace Stock (NASDAQ: FLY): Latest News, Analyst Targets, and What to Watch Before Monday’s Market Open

NEW YORK — As of 12:34 a.m. ET on Saturday, December 27, 2025, U.S. stock markets are closed and will not reopen until the next regular session on Monday, December 29. Firefly Aerospace Inc. (NASDAQ: FLY) is heading into that next session after a sharp end-of-week selloff. FLY closed Friday, Dec. 26 at $23.34, down 13.68% on the day, with after-hours trading near $23.33. StockAnalysis That move landed in a broader market context that was notably “thin” and catalyst-light: the S&P 500 slipped 0.03% on Friday to 6,929.94, with holiday-shortened volume and investors watching the seasonal “Santa Claus rally” window
27 December 2025
·····
IREN Limited Stock (NASDAQ: IREN): Latest News, Analyst Forecasts, and What to Watch Before the Next Trading Session

IREN Limited Stock (NASDAQ: IREN): Latest News, Analyst Forecasts, and What to Watch Before the Next Trading Session

IREN Limited (NASDAQ: IREN) heads into the final week of 2025 with investors balancing two powerful narratives: a rapid pivot from Bitcoin mining to AI cloud infrastructure—punctuated by a blockbuster Microsoft agreement—and the market’s growing sensitivity to how the AI data-center buildout gets financed. Late Friday in New York (9:32 p.m. ET, Dec. 26, 2025), U.S. markets are closed for the weekend, and IREN shares were last around $40.30 after a volatile session that saw the stock trade between roughly $39.53 and $42.80 on heavy volume. MarketBeat At the same time, Bitcoin is hovering near $87,383, down about 2% on
27 December 2025
·····
Impinj Stock (NASDAQ: PI) News Today: What Drove the December 24, 2025 Move—and What Analysts Forecast Next

Impinj Stock (NASDAQ: PI) News Today: What Drove the December 24, 2025 Move—and What Analysts Forecast Next

Impinj, Inc. (NASDAQ: PI) headed into the Christmas Eve session with investors debating a familiar small-cap tech paradox: a company positioned at the intersection of supply chains and “internet of things” (IoT) growth, trading at valuation levels that demand near-flawless execution. On December 24, 2025, Impinj shares finished the shortened U.S. trading day up about 3%, ending around $177–$178 per share, depending on data source. StockAnalysis+1 In a market session that typically runs thin on both liquidity and conviction, the price action still matters—because it reflects what’s currently “working” in the market narrative around RFID adoption, profitability trajectory, and the
24 December 2025
····
Ondas Holdings Inc Stock (NASDAQ: ONDS) News Today: December 23, 2025 Catalysts, Analyst Forecasts, and What Investors Are Watching

Ondas Holdings Inc Stock (NASDAQ: ONDS) News Today: December 23, 2025 Catalysts, Analyst Forecasts, and What Investors Are Watching

Ondas Holdings Inc. (NASDAQ: ONDS) has become one of the most talked-about small/mid-cap defense-tech names heading into late December, as the company stacks acquisitions, pilots, and partnerships on top of unusually heavy trading volume in the stock. As of December 23, 2025, ONDS is trading around $9.27, with a day range of roughly $9.155 to $9.660 and a 52-week range of $0.57 to $11.70—a reminder that this name has been living on a volatility roller coaster, not a gentle escalator. Investing.com+1 Below is a detailed look at the most current Ondas Holdings stock news, forecasts, and analysis as of 23.12.2025—including
23 December 2025
·····
Biogen (BIIB) Stock News Today (Dec. 22, 2025): QALSODY Data, Nasdaq-100 Exit, and Analyst Forecasts

Biogen (BIIB) Stock News Today (Dec. 22, 2025): QALSODY Data, Nasdaq-100 Exit, and Analyst Forecasts

Biogen Inc. (NASDAQ: BIIB) is in focus on Monday, December 22, 2025—a day that combines company-specific clinical headlines with a major index event for the stock. Investors are weighing fresh long‑term data for QALSODY (tofersen) in a rare genetic form of ALS, Biogen’s public statement honoring co‑founder Charles Weissmann, and the market mechanics of Biogen’s removal from the Nasdaq‑100, which becomes effective today. At the same time, Wall Street’s outlook remains mixed but active: recent analyst notes span “Reduce/Hold” to “Outperform” with price targets stretching from the low‑$140s to above $200, reflecting a debate over how quickly newer products—especially Leqembi
22 December 2025
·····
BillionToOne Stock (NASDAQ: BLLN) News, Forecasts, and Analyst Outlook for December 22, 2025

BillionToOne Stock (NASDAQ: BLLN) News, Forecasts, and Analyst Outlook for December 22, 2025

BillionToOne, Inc. (NASDAQ: BLLN) is still in the “fresh IPO” phase where price discovery happens in public—loudly. On December 22, 2025, the molecular diagnostics company’s shares were trading at $97.36, down about 5.1% on the session, after opening above $103 and swinging through a $96.61–$103.85 intraday range. There wasn’t a new company press release dated today that materially changed the story. Instead, BLLN’s move looks like part of the normal churn that follows a high-profile debut: early enthusiasm, analyst initiations, earnings/guidance digestion, and then a tug-of-war between “this could be huge” and “but how much is already priced in?” Below
22 December 2025
·····
Insmed (INSM) Stock News Today: Nasdaq‑100 Addition, Brensocatib Setback, and Updated Analyst Forecasts (Dec. 22, 2025)

Insmed (INSM) Stock News Today: Nasdaq‑100 Addition, Brensocatib Setback, and Updated Analyst Forecasts (Dec. 22, 2025)

Insmed Incorporated (NASDAQ: INSM) is ending 2025 with two headlines pulling the stock in opposite directions: fresh visibility from joining the Nasdaq‑100 Index and fresh volatility after a clinical disappointment for a key expansion effort. As of Monday, December 22, 2025 (17:56 UTC), INSM traded at $177.86, up about $3.02 (~1.7%) on the day, after swinging sharply in recent sessions. Below is what’s moving Insmed stock now, what Wall Street is forecasting after the latest developments, and the pipeline and financial checkpoints investors are watching into 2026. What’s driving Insmed stock on Dec. 22, 2025 1) Insmed officially joins the
22 December 2025
····
1 2 3

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Anglo American share price slips as BofA turns neutral after copper outlook cut

Anglo American share price slips as BofA turns neutral after copper outlook cut

7 February 2026
Anglo American shares closed down 0.75% at 3,435 pence Friday after BofA Global Research downgraded the miner to “neutral” and raised its price target to 3,600 pence. Anglo cut its 2026 copper production guidance and warned of continued weakness at De Beers. The company expects $200 million in charges tied to its Chile copper operations in the second half of 2025.
Go toTop